Cite

HARVARD Citation

    Kramer, K. et al. (2018). A phase II study of radioimmunotherapy with intraventricular 131I‐3F8 for medulloblastoma. Pediatric blood & cancer. 65 (1), p. n/a. [Online]. 
  
Back to record